Search Results 151-160 of 17214 for ulcerative colitis
A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis. Print ...
Mayo Clinic researcher Edward V. Loftus Jr., M.D., is a gastroenterologist studying ulcerative colitis and Crohn's disease.
A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis · More about research at Mayo ...
Inflammatory bowel disease (Crohn's disease/ulcerative colitis) · Pediatric to Adult care transition · Pediatric IBD clinical trials · Stem cell trials/research ...
Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report. Inflamm Bowel Dis. 2024 Jul 5 Epub 2024 July 05. View PubMed; Bhat ...
... (IBD) (Crohn's disease or ulcerative colitis [UC]) in symptomatic remission with moderate to severe endoscopic inflammation despite optimization of index TIM ...
11–16, in San Diego. More than 1.5 million Americans have Crohn's disease or ulcerative colitis , the most common forms of inflammatory bowel disease (IBD).
Ha, M.D., specializes in the diagnosis and treatment of the inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis. Her IBD clinical care ...
... ulcerative colitis, ankylosing spondylitis, and polyarticular course juvenile idiopathic arthritis (pcJIA) in patients who have taken other medicines (eg ...
Description. Etrasimod is used to treat moderate to severe active ulcerative colitis. This medicine is available only with your doctor's prescription. This ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.